-
2
-
-
84863416147
-
-
Office of Cancer Genomics
-
National Cancer Institute: Office of Cancer Genomics. http://ocg.cancer.gov/
-
-
-
-
3
-
-
33749993417
-
The consensus coding sequences of human breast and colorectal cancers
-
DOI 10.1126/science.1133427
-
Sjöblom T, Jones S, Wood LD, et al: The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274, 2006 (Pubitemid 44571966)
-
(2006)
Science
, vol.314
, Issue.5797
, pp. 268-274
-
-
Sjoblom, T.1
Jones, S.2
Wood, L.D.3
Parsons, D.W.4
Lin, J.5
Barber, T.D.6
Mandelker, D.7
Leary, R.J.8
Ptak, J.9
Silliman, N.10
Szabo, S.11
Buckhaults, P.12
Farrell, C.13
Meeh, P.14
Markowitz, S.D.15
Willis, J.16
Dawson, D.17
Willson, J.K.V.18
Gazdar, A.F.19
Hartigan, J.20
Wu, L.21
Liu, C.22
Parmigiani, G.23
Park, B.H.24
Bachman, K.E.25
Papadopoulos, N.26
Vogelstein, B.27
Kinzler, K.W.28
Velculescu, V.E.29
more..
-
4
-
-
72849144434
-
Sequencing technologies: The next generation
-
Metzker ML: Sequencing technologies: The next generation. Nat Rev Genet 11:31-46, 2009
-
(2009)
Nat Rev Genet
, vol.11
, pp. 31-46
-
-
Metzker, M.L.1
-
5
-
-
53649106195
-
Next-generation DNA sequencing
-
Shendure J, Ji H: Next-generation DNA sequencing. Nat Biotechnol 26:1135-1145, 2009
-
(2009)
Nat Biotechnol
, vol.26
, pp. 1135-1145
-
-
Shendure, J.1
Ji, H.2
-
6
-
-
7244245762
-
Finishing the euchromatic sequence of the human genome
-
International Human Genome Consortium
-
International Human Genome Consortium: Finishing the euchromatic sequence of the human genome. Nature 431:931-945, 1992
-
(1992)
Nature
, vol.431
, pp. 931-945
-
-
-
7
-
-
77957252585
-
Application of second-generation sequencing to cancer genomics
-
Robison K: Application of second-generation sequencing to cancer genomics. Brief Bioinform 11:524-534, 2010
-
(2010)
Brief Bioinform
, vol.11
, pp. 524-534
-
-
Robison, K.1
-
8
-
-
44249090038
-
Molecular profiling in the age of cancer genomics
-
DOI 10.1586/14737159.8.3.263
-
Lin J, Li M: Molecular profiling in the age of cancer genomics. Exp Rev Mol Diagn 8:263-276, 2008 (Pubitemid 351724706)
-
(2008)
Expert Review of Molecular Diagnostics
, vol.8
, Issue.3
, pp. 263-276
-
-
Lin, J.1
Li, M.2
-
9
-
-
80051732262
-
Accurate and comprehensive sequencing of personal genomes
-
Ajay SS, Parker SC, Abaan HO, et al: Accurate and comprehensive sequencing of personal genomes. Genome Res 21:1498-1505, 2011
-
(2011)
Genome Res
, vol.21
, pp. 1498-1505
-
-
Ajay, S.S.1
Parker, S.C.2
Abaan, H.O.3
-
10
-
-
79551651006
-
Advances in whole genome sequencing technology
-
Zhao J, Grant SF: Advances in whole genome sequencing technology. Curr Pharm Biotechnol 12:293-305, 2011
-
(2011)
Curr Pharm Biotechnol
, vol.12
, pp. 293-305
-
-
Zhao, J.1
Grant, S.F.2
-
11
-
-
58149234737
-
Real-time DNA sequencing from single polymerase molecules
-
Eid J, Fehr A, Gray J, et al: Real-time DNA sequencing from single polymerase molecules. Science 323:133-138, 2009
-
(2009)
Science
, vol.323
, pp. 133-138
-
-
Eid, J.1
Fehr, A.2
Gray, J.3
-
12
-
-
80052173621
-
Open-source genomic analysis of shiga-toxin-producing E. coli O104:H4
-
Rohde H, Qin J, Cui Y, et al: Open-source genomic analysis of shiga-toxin-producing E. coli O104:H4. N Engl J Med 365:718-724, 2011
-
(2011)
N Engl J Med
, vol.365
, pp. 718-724
-
-
Rohde, H.1
Qin, J.2
Cui, Y.3
-
13
-
-
0037236218
-
Techniques patents for SNP genotyping
-
DOI 10.1517/phgs.4.1.67.22582
-
Twyman RM, Primrose SB: Techniques patents for SNP genotyping. Pharmacogenomics 4:67-79, 2003 (Pubitemid 36104657)
-
(2003)
Pharmacogenomics
, vol.4
, Issue.1
, pp. 67-79
-
-
Twyman, R.M.1
Primrose, S.B.2
-
14
-
-
34247100296
-
Analytical validation of genotyping assays in the biomarker laboratory
-
DOI 10.2217/14622416.8.4.353
-
Isler JA, Vesterqvist OE, Burczynski ME: Analytical validation of genotyping assays in the biomarker laboratory. Pharmacogenomics 8:353-368, 2007 (Pubitemid 46585498)
-
(2007)
Pharmacogenomics
, vol.8
, Issue.4
, pp. 353-368
-
-
Isler, J.A.1
Vesterqvist, O.E.2
Burczynski, M.E.3
-
15
-
-
78649321882
-
New technologies in the genetic approach to sudden cardiac death in the young
-
Brion M, Quintela I, Sobrino B, et al: New technologies in the genetic approach to sudden cardiac death in the young. Forensic Sci Int 203:15-24, 2010
-
(2010)
Forensic Sci Int
, vol.203
, pp. 15-24
-
-
Brion, M.1
Quintela, I.2
Sobrino, B.3
-
16
-
-
0036360439
-
Progress in high throughput SNP genotyping methods
-
DOI 10.1038/sj.tpj.6500094
-
Tsuchihashi Z, Dracopoli N: Progress in high throughput SNP genotyping methods. Biosystems 2:103-110, 2002 (Pubitemid 34982213)
-
(2002)
Pharmacogenomics Journal
, vol.2
, Issue.2
, pp. 103-110
-
-
Tsuchihashi, Z.1
Dracopoli, N.C.2
-
17
-
-
3242673452
-
A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: Accuracy, cost, and throughput
-
DOI 10.1016/j.jbbm.2003.11.005, PII S0165022X03002148
-
Pati N, Schowinsky V, Kokanovic O, et al: A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: Accuracy, cost, and throughput. J Biochem Biophys Methods 60:1-12, 2004 (Pubitemid 38952847)
-
(2004)
Journal of Biochemical and Biophysical Methods
, vol.60
, Issue.1
, pp. 1-12
-
-
Pati, N.1
Schowinsky, V.2
Kokanovic, O.3
Magnuson, V.4
Ghosh, S.5
-
18
-
-
4344584076
-
Evaluation and validation of the ABI 3700, ABI 3100, and the MegaBACE 1000 capillary array electrophoresis instruments for use with short tandem repeat microsatellite typing in a forensic environment
-
DOI 10.1002/elps.200305976
-
Koumi P, Green HE, Hartley S, et al: Evaluation and validation of the ABI 3700, ABI 3100, and the MegaBACE 1000 capillary array electrophoresis instruments for use with short tandem repeat microsatellite typing in a forensic environment. Electrophoresis 25:2227-2241, 2004 (Pubitemid 39136345)
-
(2004)
Electrophoresis
, vol.25
, Issue.14
, pp. 2227-2241
-
-
Koumi, P.1
Green, H.E.2
Hartley, S.3
Jordan, D.4
Lahec, S.5
Livett, R.J.6
Tsang, K.W.7
Ward, D.M.8
-
19
-
-
73449095762
-
The pitfalls of platform comparison: DNA copy number array technologies assessed
-
Curtis C, Lynch AG, Dunning MJ, et al: The pitfalls of platform comparison: DNA copy number array technologies assessed. BMC Genomics 10: 588, 2009
-
(2009)
BMC Genomics
, vol.10
, pp. 588
-
-
Curtis, C.1
Lynch, A.G.2
Dunning, M.J.3
-
20
-
-
62549112118
-
Basic principles and technologies for deciphering the genetic map of cancer
-
Voidonikolas G, Kreml SS, Chen C, et al: Basic principles and technologies for deciphering the genetic map of cancer. World J Surg 33:615-629, 2009
-
(2009)
World J Surg
, vol.33
, pp. 615-629
-
-
Voidonikolas, G.1
Kreml, S.S.2
Chen, C.3
-
21
-
-
79952198057
-
Exome sequencing: The sweet spot before whole genomes
-
Teer JK, Mullikin JC: Exome sequencing: The sweet spot before whole genomes. Hum Mol Genet 19:145-151, 2010
-
(2010)
Hum Mol Genet
, vol.19
, pp. 145-151
-
-
Teer, J.K.1
Mullikin, J.C.2
-
22
-
-
33847293670
-
High-throughput oncogene mutation profiling in human cancer
-
DOI 10.1038/ng1975, PII NG1975
-
Thomas RK, Baker AC, Debiasi RM, et al: High-throughput oncogene mutation profiling in human cancer. Nature Genet 39:347-351, 2007 (Pubitemid 46328493)
-
(2007)
Nature Genetics
, vol.39
, Issue.3
, pp. 347-351
-
-
Thomas, R.K.1
Baker, A.C.2
DeBiasi, R.M.3
Winckler, W.4
LaFramboise, T.5
Lin, W.M.6
Wang, M.7
Feng, W.8
Zander, T.9
MacConnaill, L.E.10
Lee, J.C.11
Nicoletti, R.12
Hatton, C.13
Goyette, M.14
Girard, L.15
Majmudar, K.16
Ziaugra, L.17
Wong, K.-K.18
Gabriel, S.19
Beroukhim, R.20
Peyton, M.21
Barretina, J.22
Dutt, A.23
Emery, C.24
Greulich, H.25
Shah, K.26
Sasaki, H.27
Gazdar, A.28
Minna, J.29
Armstrong, S.A.30
Mellinghoff, I.K.31
Hodi, F.S.32
Dranoff, G.33
Mischel, P.S.34
Cloughesy, T.F.35
Nelson, S.F.36
Liau, L.M.37
Mertz, K.38
Rubin, M.A.39
Moch, H.40
Loda, M.41
Catalona, W.42
Fletcher, J.43
Signoretti, S.44
Kaye, F.45
Anderson, K.C.46
Demetri, G.D.47
Dummer, R.48
Wagner, S.49
Herlyn, M.50
Sellers, W.R.51
Meyerson, M.52
Garraway, L.A.53
more..
-
23
-
-
77954566882
-
Rapid targeted mutational analysis of human tumours: A clinical platform to guide personalized cancer medicine
-
Dias-Santagata D, Akhavanfard S, David SS, et al: Rapid targeted mutational analysis of human tumours: A clinical platform to guide personalized cancer medicine. EMBO Mol Med 2:146-158, 2010
-
(2010)
EMBO Mol Med
, vol.2
, pp. 146-158
-
-
Dias-Santagata, D.1
Akhavanfard, S.2
David, S.S.3
-
24
-
-
70849116358
-
Profiling critical cancer gene mutations in clinical tumor samples
-
MacConaill LE, Campbell CD, Kehoe SM, et al: Profiling critical cancer gene mutations in clinical tumor samples. PloS One 4:e7887, 2009
-
(2009)
PloS One
, vol.4
-
-
MacConaill, L.E.1
Campbell, C.D.2
Kehoe, S.M.3
-
25
-
-
62449090881
-
Guidelines for human epidermal growth factor receptor 2 testing: Biologic and methodologic considerations
-
Sauter G, Lee J, Bartlett JM, et al: Guidelines for human epidermal growth factor receptor 2 testing: Biologic and methodologic considerations. J Clin Oncol 27:1323-1333, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 1323-1333
-
-
Sauter, G.1
Lee, J.2
Bartlett, J.M.3
-
26
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
Slamon DJ, Leyland-Jones B, Shak S, et al: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792, 2001 (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
27
-
-
77956262693
-
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
-
Bang YJ, Van Cutsem E, Feyereislova A, et al: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 376:687-697, 2010
-
(2010)
Lancet
, vol.376
, pp. 687-697
-
-
Bang, Y.J.1
Van Cutsem, E.2
Feyereislova, A.3
-
28
-
-
23444459574
-
Array CGH technologies and their applications to cancer genomes
-
Davies JJ, Wilson IM, Lam WL: Array CGH technologies and their applications to cancer genomes. Chromosome Res 13:237-248, 2005
-
(2005)
Chromosome Res
, vol.13
, pp. 237-248
-
-
Davies, J.J.1
Wilson, I.M.2
Lam, W.L.3
-
29
-
-
77952499379
-
Multiplatform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number
-
Andrews J, Kennette W, Pilon J, et al: Multiplatform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number. PloS One 5:e8665, 2010
-
(2010)
PloS One
, vol.5
-
-
Andrews, J.1
Kennette, W.2
Pilon, J.3
-
30
-
-
39649084637
-
Bioinformatics challenges of new sequencing technology
-
Pop M, Salzberg SL: Bioinformatics challenges of new sequencing technology. Trends Genet 24:142-149, 2008
-
(2008)
Trends Genet
, vol.24
, pp. 142-149
-
-
Pop, M.1
Salzberg, S.L.2
-
31
-
-
33745699558
-
Current bioinformatics tools in genomic biomedical research
-
Teufel A, Krupp M, Weinmann A, et al: Current bioinformatics tools in genomic biomedical research. Int J Mol Med 17:967-973, 2006
-
(2006)
Int J Mol Med
, vol.17
, pp. 967-973
-
-
Teufel, A.1
Krupp, M.2
Weinmann, A.3
-
32
-
-
35748932917
-
A review of feature selection techniques in bioinformatics
-
DOI 10.1093/bioinformatics/btm344
-
Saeys Y, Inza I, Larrañaga P: A review of feature selection techniques in bioinformatics. Bioinformatics 23:2507-2517, 2007 (Pubitemid 350048351)
-
(2007)
Bioinformatics
, vol.23
, Issue.19
, pp. 2507-2517
-
-
Saeys, Y.1
Inza, I.2
Larranaga, P.3
-
33
-
-
37549024563
-
A bioinformatic filter for improved base-call accuracy and polymorphism detection using the Affymetrix GeneChip whole-genome resequencing platform
-
Pandya GA, Holmes MH, Sunkara S, et al: A bioinformatic filter for improved base-call accuracy and polymorphism detection using the Affymetrix GeneChip whole-genome resequencing platform. Nucleic Acids Res 35:e148, 2007
-
(2007)
Nucleic Acids Res
, vol.35
-
-
Pandya, G.A.1
Holmes, M.H.2
Sunkara, S.3
-
34
-
-
77951139631
-
Genome remodelling in a basal-like breast cancer metastasis and xenograft
-
Ding L, Ellis MJ, Li S, et al: Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464:999-1005, 2010
-
(2010)
Nature
, vol.464
, pp. 999-1005
-
-
Ding, L.1
Ellis, M.J.2
Li, S.3
-
35
-
-
70149093912
-
Recurring mutations found by sequencing an acute myeloid leukemia genome
-
Mardis ER, Ding L, Dooling DJ, et al: Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058-1066, 2009
-
(2009)
N Engl J Med
, vol.361
, pp. 1058-1066
-
-
Mardis, E.R.1
Ding, L.2
Dooling, D.J.3
-
36
-
-
74449085934
-
A small-cell lung cancer genome with complex signatures of tobacco exposure
-
Pleasance ED, Stephens PJ, O'Meara S, et al: A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184-190, 2010
-
(2010)
Nature
, vol.463
, pp. 184-190
-
-
Pleasance, E.D.1
Stephens, P.J.2
O'Meara, S.3
-
37
-
-
74449093973
-
A comprehensive catalogue of somatic mutations from a human cancer genome
-
Pleasance ED, Cheetham RK, Stephens PJ, et al: A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196, 2010
-
(2010)
Nature
, vol.463
, pp. 191-196
-
-
Pleasance, E.D.1
Cheetham, R.K.2
Stephens, P.J.3
-
38
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
Cancer Genome Atlas Research Network
-
Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068, 2008
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
39
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons DW, Jones S, Zhang X, et al: An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812, 2008
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
-
40
-
-
79951497419
-
The genomic complexity of primary human prostate cancer
-
Berger MF, Lawrence MS, Demichelis F, et al: The genomic complexity of primary human prostate cancer. Nature 470:214-220, 2011
-
(2011)
Nature
, vol.470
, pp. 214-220
-
-
Berger, M.F.1
Lawrence, M.S.2
Demichelis, F.3
-
41
-
-
55549101623
-
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
-
Ley TJ, Mardis ER, Ding L, et al: DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-72, 2008
-
(2008)
Nature
, vol.456
, pp. 66-72
-
-
Ley, T.J.1
Mardis, E.R.2
Ding, L.3
-
43
-
-
77951115122
-
International network of cancer genome projects
-
International Cancer Genome Consortium
-
International Cancer Genome Consortium: International network of cancer genome projects. Nature 464:993-998, 2010
-
(2010)
Nature
, vol.464
, pp. 993-998
-
-
-
44
-
-
13144306071
-
Genome-wide association studies for common diseases and complex traits
-
DOI 10.1038/nrg1521
-
Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. Nature Rev Genet 6:95-108, 2005 (Pubitemid 40179532)
-
(2005)
Nature Reviews Genetics
, vol.6
, Issue.2
, pp. 95-108
-
-
Hirschhorn, J.N.1
Daly, M.J.2
-
45
-
-
79959838081
-
Integrated genomic analyses of ovarian carcinoma
-
Cancer Genome Atlas Research Network
-
Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature 474:609-615, 2011
-
(2011)
Nature
, vol.474
, pp. 609-615
-
-
-
46
-
-
79960036578
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
-
Puente XS, Pinyol M, Quesada V, et al: Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101-105, 2011
-
(2011)
Nature
, vol.475
, pp. 101-105
-
-
Puente, X.S.1
Pinyol, M.2
Quesada, V.3
-
47
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, et al: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806, 2008
-
(2008)
Science
, vol.321
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
-
48
-
-
79951494668
-
Initial genome sequencing and analysis of multiple myeloma
-
Chapman MA, Lawrence MS, Keats JJ, et al: Initial genome sequencing and analysis of multiple myeloma. Nature 471:467-472, 2011
-
(2011)
Nature
, vol.471
, pp. 467-472
-
-
Chapman, M.A.1
Lawrence, M.S.2
Keats, J.J.3
-
49
-
-
85027927831
-
High-resolution characterization of a hepatocellular carcinoma genome
-
Totoki Y, Tatsuno K, Yamamoto S, et al: High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 43:464-469, 2011
-
(2011)
Nat Genet
, vol.43
, pp. 464-469
-
-
Totoki, Y.1
Tatsuno, K.2
Yamamoto, S.3
-
50
-
-
40849139208
-
Epigenetics in cancer
-
Esteller M: Epigenetics in cancer. N Engl J Med 358:1148-1159, 2008
-
(2008)
N Engl J Med
, vol.358
, pp. 1148-1159
-
-
Esteller, M.1
-
51
-
-
77955654135
-
Expectations, validity, and reality in gene expression profiling
-
Kim K, Zakharkin SO, Allison DB: Expectations, validity, and reality in gene expression profiling. J Clin Epidemiol 63:950-959, 2010
-
(2010)
J Clin Epidemiol
, vol.63
, pp. 950-959
-
-
Kim, K.1
Zakharkin, S.O.2
Allison, D.B.3
-
52
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou CM, Sørlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sørlie, T.2
Eisen, M.B.3
-
53
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
DOI 10.1056/NEJMoa021967
-
Vijver MJ van de, He YD, Veer LJ van't, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002 (Pubitemid 35461656)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.25
, pp. 1999-2009
-
-
Van De, V.M.J.1
He, Y.D.2
Van 'T, V.L.J.3
Dai, H.4
Hart, A.A.M.5
Voskuil, D.W.6
Schreiber, G.J.7
Peterse, J.L.8
Roberts, C.9
Marton, M.J.10
Parrish, M.11
Atsma, D.12
Witteveen, A.13
Glas, A.14
Delahaye, L.15
Van Der, V.T.16
Bartelink, H.17
Rodenhuis, S.18
Rutgers, E.T.19
Friend, S.H.20
Bernards, R.21
more..
-
54
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
DOI 10.1056/NEJMoa041588
-
Paik S, Shak S, Tang G, et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-2826, 2004 (Pubitemid 40051905)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.27
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
Baehner, F.L.7
Walker, M.G.8
Watson, D.9
Park, T.10
Hiller, W.11
Fisher, E.R.12
Wickerham, D.L.13
Bryant, J.14
Wolmark, N.15
-
55
-
-
20544442173
-
Gene profiling of immune responses against tumors
-
DOI 10.1016/j.coi.2005.05.007, PII S0952791505000786
-
Wang E, Panelli MC, Marincola FM: Gene profiling of immune responses against tumors. Cur Opin Immunol 17:423-427, 2005 (Pubitemid 40848546)
-
(2005)
Current Opinion in Immunology
, vol.17
, Issue.4 SPEC. ISS.
, pp. 423-427
-
-
Wang, E.1
Panelli, M.C.2
Marincola, F.M.3
-
56
-
-
0036548986
-
Spinning molecular immunology into successful immunotherapy
-
Pardoll DM: Spinning molecular immunology into successful immunotherapy. Nature Rev Immunol 2:227-238, 2002
-
(2002)
Nature Rev Immunol
, vol.2
, pp. 227-238
-
-
Pardoll, D.M.1
-
57
-
-
33749319703
-
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
-
DOI 10.1126/science.1129139
-
Galon J, Costes A, Sanchez-Cabo F, et al: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964, 2006 (Pubitemid 44498003)
-
(2006)
Science
, vol.313
, Issue.5795
, pp. 1960-1964
-
-
Galon, J.1
Costes, A.2
Sanchez-Cabo, F.3
Kirilovsky, A.4
Mlecnik, B.5
Lagorce-Pages, C.6
Tosolini, M.7
Camus, M.8
Berger, A.9
Wind, P.10
Zinzindohoue, F.11
Bruneval, P.12
Cugnenc, P.-H.13
Trajanoski, Z.14
Fridman, W.-H.15
Pages, F.16
-
58
-
-
77953233668
-
Gene-expression profiling in vaccine therapy and immunotherapy for cancer
-
Bedognetti D, Wang E, Sertoli MR, et al: Gene-expression profiling in vaccine therapy and immunotherapy for cancer. Exp Rev Vaccines 9:555-565, 2010
-
(2010)
Exp Rev Vaccines
, vol.9
, pp. 555-565
-
-
Bedognetti, D.1
Wang, E.2
Sertoli, M.R.3
-
59
-
-
80052512017
-
Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling
-
Coppola D, Nebozhyn M, Khalil F, et al: Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Path 179:37-45, 2011
-
(2011)
Am J Path
, vol.179
, pp. 37-45
-
-
Coppola, D.1
Nebozhyn, M.2
Khalil, F.3
-
60
-
-
77955976922
-
The grand challenge to decipher the cancer proteome
-
Hanash S, Taguchi A: The grand challenge to decipher the cancer proteome. Nature Rev Cancer 10:652-660, 2010
-
(2010)
Nature Rev Cancer
, vol.10
, pp. 652-660
-
-
Hanash, S.1
Taguchi, A.2
-
61
-
-
77950448106
-
Point: Hypotheses first
-
Weinberg R: Point: Hypotheses first. Nature 464:678, 2010
-
(2010)
Nature
, vol.464
, pp. 678
-
-
Weinberg, R.1
-
62
-
-
34547641984
-
Cancer genome sequencing: The challenges ahead
-
Heng HH: Cancer genome sequencing: The challenges ahead. Bioessays 29:783-794, 2007
-
(2007)
Bioessays
, vol.29
, pp. 783-794
-
-
Heng, H.H.1
-
63
-
-
70249111091
-
Targeted capture and massively parallel sequencing of 12 human exomes
-
Ng SB, Turner EH, Robertson PD, et al: Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461:272-276, 2009
-
(2009)
Nature
, vol.461
, pp. 272-276
-
-
Ng, S.B.1
Turner, E.H.2
Robertson, P.D.3
-
64
-
-
66149092582
-
Exome sequencing takes centre stage in cancer profiling
-
Maher B: Exome sequencing takes centre stage in cancer profiling. Nature 459:146-147, 2009
-
(2009)
Nature
, vol.459
, pp. 146-147
-
-
Maher, B.1
-
65
-
-
77952718611
-
Screening the human exome: A comparison of whole genome and whole transcriptome sequencing
-
Cirulli ET, Singh A, Shianna KV, et al: Screening the human exome: A comparison of whole genome and whole transcriptome sequencing. Genome Biol 11:R57, 2010
-
(2010)
Genome Biol
, vol.11
-
-
Cirulli, E.T.1
Singh, A.2
Shianna, K.V.3
-
67
-
-
75549085403
-
Whole-genome cancer analysis as an approach to deeper understanding of tumour biology
-
Strausberg RL, Simpson AJ: Whole-genome cancer analysis as an approach to deeper understanding of tumour biology. Br J Cancer 102:243-248, 2010
-
(2010)
Br J Cancer
, vol.102
, pp. 243-248
-
-
Strausberg, R.L.1
Simpson, A.J.2
-
68
-
-
50849127837
-
Genetic variation in an individual human exome
-
Ng PC, Levy S, Huang J, et al: Genetic variation in an individual human exome. PLoS Genet 4:e1000160, 2008
-
(2008)
PLoS Genet
, vol.4
-
-
Ng, P.C.1
Levy, S.2
Huang, J.3
-
69
-
-
72449209239
-
Next-generation sequencing of cancer genomes: Back to the future
-
Walter MJ, Graubert TA, Dipersio JF, et al: Next-generation sequencing of cancer genomes: Back to the future. Per Med 6:653, 2009
-
(2009)
Per Med
, vol.6
, pp. 653
-
-
Walter, M.J.1
Graubert, T.A.2
Dipersio, J.F.3
-
70
-
-
73949109877
-
Our changing view of the genomic landscape of cancer
-
Bell DW: Our changing view of the genomic landscape of cancer. J Path 220:231-243, 2010
-
(2010)
J Path
, vol.220
, pp. 231-243
-
-
Bell, D.W.1
-
71
-
-
79958817037
-
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
-
epub ahead of print on March 31, 2011
-
Tran B, Kopetz S, Tie J, et al: Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer. Cancer [epub ahead of print on March 31, 2011]
-
Cancer
-
-
Tran, B.1
Kopetz, S.2
Tie, J.3
-
72
-
-
75749096130
-
Cancer genome sequencing: A review
-
Mardis ER, Wilson RK: Cancer genome sequencing: A review. Hum Mol Genet 18:R163-R168, 2009
-
(2009)
Hum Mol Genet
, vol.18
-
-
Mardis, E.R.1
Wilson, R.K.2
-
73
-
-
67649500009
-
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
-
Scott KL, Kabbarah O, Liang MC, et al: GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459:1085-1090, 2009
-
(2009)
Nature
, vol.459
, pp. 1085-1090
-
-
Scott, K.L.1
Kabbarah, O.2
Liang, M.C.3
-
74
-
-
0038745614
-
Integrating biological databases
-
Stein LD: Integrating biological databases. Nat Rev Genet 4:337-345, 2003
-
(2003)
Nat Rev Genet
, vol.4
, pp. 337-345
-
-
Stein, L.D.1
-
76
-
-
3042562270
-
Genomics, prior probability, and statistical tests of multiple hypotheses
-
DOI 10.1101/gr.2156804
-
Manly KF, Nettleton D, Hwang JT: Genomics, prior probability, and statistical tests of multiple hypotheses. Genome Res 14:997-1001, 2004 (Pubitemid 38811535)
-
(2004)
Genome Research
, vol.14
, Issue.6
, pp. 997-1001
-
-
Manly, K.F.1
Nettleton, D.2
Gene, H.J.T.3
-
77
-
-
0036574916
-
Statistical issues with microarrays: Processing and analysis
-
DOI 10.1016/S0168-9525(02)02665-3, PII S0168952502026653
-
Nadon R, Shoemaker J: Statistical issues with microarrays: Processing and analysis. Trends Genet 18:265-271, 2002 (Pubitemid 34607142)
-
(2002)
Trends in Genetics
, vol.18
, Issue.5
, pp. 265-271
-
-
Nadon, R.1
Shoemaker, J.2
-
78
-
-
38049040796
-
Multiple testing in the genomics era: Findings from Genetic Analysis Workshop 15, Group 15
-
Martin LJ, Woo JG, Avery CL, et al: Multiple testing in the genomics era: Findings from Genetic Analysis Workshop 15, Group 15. Genet Epidemiol 31:124-131, 2007
-
(2007)
Genet Epidemiol
, vol.31
, pp. 124-131
-
-
Martin, L.J.1
Woo, J.G.2
Avery, C.L.3
-
80
-
-
33845886440
-
Lapatinib plus capecitabine for HER2-positive advanced breast cancer
-
DOI 10.1056/NEJMoa064320
-
Geyer CE, Forster J, Lindquist D, et al: Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355:2733-2743, 2006 (Pubitemid 46021510)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.26
, pp. 2733-2743
-
-
Geyer, C.E.1
Forster, J.2
Lindquist, D.3
Chan, S.4
Romieu, C.G.5
Pienkowski, T.6
Jagiello-Gruszfeld, A.7
Crown, J.8
Chan, A.9
Kaufman, B.10
Skarlos, D.11
Campone, M.12
Davidson, N.13
Berger, M.14
Oliva, C.15
Rubin, S.D.16
Stein, S.17
Cameron, D.18
-
81
-
-
69949162760
-
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
-
Mok TS, Wu YL, Thongprasert S, et al: Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947-957, 2011
-
(2011)
N Engl J Med
, vol.361
, pp. 947-957
-
-
Mok, T.S.1
Wu, Y.L.2
Thongprasert, S.3
-
82
-
-
56249109644
-
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase III trial
-
Kim E, Hirsh V, Mok T, et al: Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase III trial. Lancet 372:1809-1818, 2008
-
(2008)
Lancet
, vol.372
, pp. 1809-1818
-
-
Kim, E.1
Hirsh, V.2
Mok, T.3
-
83
-
-
79959795786
-
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
-
Chapman PB, Hauschild A, Robert C, et al: Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364:2507-2516, 2011
-
(2011)
N Engl J Med
, vol.364
, pp. 2507-2516
-
-
Chapman, P.B.1
Hauschild, A.2
Robert, C.3
-
84
-
-
0037165261
-
Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma
-
DOI 10.1056/NEJMoa011795
-
Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002 (Pubitemid 34438862)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.4
, pp. 235-242
-
-
Coiffier, B.1
Lepage, E.2
Briere, J.3
Herbrecht, R.4
Tilly, H.5
Bouabdallah, R.6
Morel, P.7
Van Den, N.E.8
Salles, G.9
Gaulard, P.10
Reyes, F.11
Lederlin, P.12
Gisselbrecht, C.13
-
85
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF, et al: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711-723, 2010
-
(2010)
N Engl J Med
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
-
86
-
-
77955066199
-
Sipuleucel-T immunotherapy for castration-resistant prostate cancer
-
Kantoff PW, Higano CS, Shore ND, et al: Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411-422, 2010
-
(2010)
N Engl J Med
, vol.363
, pp. 411-422
-
-
Kantoff, P.W.1
Higano, C.S.2
Shore, N.D.3
-
87
-
-
77954938591
-
Future of personalized medicine in oncology: A systems biology approach
-
Gonzalez-Angulo AM, Hennessy BT, Mills GB: Future of personalized medicine in oncology: A systems biology approach. J Clin Oncol 28:2777-2783, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 2777-2783
-
-
Gonzalez-Angulo, A.M.1
Hennessy, B.T.2
Mills, G.B.3
-
88
-
-
79951865370
-
Clinical implications of the cancer genome
-
Macconaill LE, Garraway LA: Clinical implications of the cancer genome. J Clin Oncol 28:5219-5228, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 5219-5228
-
-
Macconaill, L.E.1
Garraway, L.A.2
-
89
-
-
77949667760
-
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents
-
Dancey JE, Dobbin KK, Groshen S, et al: Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents. Clin Cancer Res 16:1745-1755, 2010
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1745-1755
-
-
Dancey, J.E.1
Dobbin, K.K.2
Groshen, S.3
-
90
-
-
79951897927
-
Selecting systemic cancer therapy one patient at a time: Is there a role for molecular profiling of individual patients with advanced solid tumors?
-
Doroshow JH: Selecting systemic cancer therapy one patient at a time: Is there a role for molecular profiling of individual patients with advanced solid tumors? J Clin Oncol 28:4869-4871, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 4869-4871
-
-
Doroshow, J.H.1
-
91
-
-
79951906119
-
Pilot study using molecular profiling of patients tumors to find potential targets and select treatments for their refractory cancers
-
Von Hoff DD, Stephenson JJ Jr, Rosen P, et al: Pilot study using molecular profiling of patients tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol 28:4877-4883, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 4877-4883
-
-
Von Hoff, D.D.1
Stephenson Jr., J.J.2
Rosen, P.3
-
92
-
-
84855558810
-
Personalized medicine in a phase I clinical trials program: The M. D. Anderson Cancer Center initiative
-
suppl; abstr CRC2500
-
Tsimberidou AM, Iskander NG, Hong DS, et al: Personalized medicine in a phase I clinical trials program: The M. D. Anderson Cancer Center initiative. J Clin Oncol 29:18s, 2011 (suppl; abstr CRC2500)
-
(2011)
J Clin Oncol
, vol.29
-
-
Tsimberidou, A.M.1
Iskander, N.G.2
Hong, D.S.3
-
93
-
-
79957857433
-
The BATTLE Trial: Personalizing Therapy for Lung Cancer
-
Kim ES, Herbst RS, Wistuba II, et al: The BATTLE Trial: Personalizing Therapy for Lung Cancer. Cancer Discov 1:44-53, 2011
-
(2011)
Cancer Discov
, vol.1
, pp. 44-53
-
-
Kim, E.S.1
Herbst, R.S.2
Wistuba, I.I.3
-
94
-
-
70649113052
-
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
-
Ross CJ, Katzov-Eckert H, Dubé MP, et al: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature Genet 41:1345-1349, 2009
-
(2009)
Nature Genet
, vol.41
, pp. 1345-1349
-
-
Ross, C.J.1
Katzov-Eckert, H.2
Dubé, M.P.3
-
95
-
-
42949174211
-
Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer
-
de Haas EC, Zwart N, Meijer C, et al: Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol 26:1817-1823, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 1817-1823
-
-
De Haas, E.C.1
Zwart, N.2
Meijer, C.3
-
96
-
-
33750583902
-
Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: Practical pharmacogenomics arrives in cancer therapy
-
DOI 10.1200/JCO.2006.07.3031
-
O'Dwyer PJ, Catalano RB: Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: Practical pharmacogenomics arrives in cancer therapy. J Clin Oncol 24:4534-4538, 2006 (Pubitemid 46630947)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.28
, pp. 4534-4538
-
-
O'Dwyer, P.J.1
Catalano, R.B.2
-
97
-
-
84863403954
-
Generation of a panel of druggable mutation cancer genes for molecular profiling in a feasibility study of somatic mutation genotyping and targeted exome sequencing: OICR-PMH study
-
Presented at the
-
Tran B, Dancey JE, Kamel-Reid S, et al: Generation of a panel of druggable mutation cancer genes for molecular profiling in a feasibility study of somatic mutation genotyping and targeted exome sequencing: OICR-PMH study. Presented at the European Organisation for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Annual Meeting on Molecular Markers in Cancer, Brussels, Belgium, October 27-29, 2011
-
European Organisation for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Annual Meeting on Molecular Markers in Cancer, Brussels, Belgium, October 27-29, 2011
-
-
Tran, B.1
Dancey, J.E.2
Kamel-Reid, S.3
-
98
-
-
84863407177
-
Comparative genomic analysis of primary versus metastasis in colorectal carcinomas
-
suppl; abstr 10500
-
Vakiani E, Janakiraman M, Shen R, et al: Comparative genomic analysis of primary versus metastasis in colorectal carcinomas. J Clin Oncol 29:15s, 2011 (suppl; abstr 10500)
-
(2011)
J Clin Oncol
, vol.29
-
-
Vakiani, E.1
Janakiraman, M.2
Shen, R.3
-
99
-
-
79952463028
-
Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation
-
Tie J, Gibbs P, Lipton L, et al: Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation. Int J Cancer 128:2075-2084, 2010
-
(2010)
Int J Cancer
, vol.128
, pp. 2075-2084
-
-
Tie, J.1
Gibbs, P.2
Lipton, L.3
-
100
-
-
84857568955
-
Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer
-
Amir E, Miller N, Geddie W, et al: Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol 30:587-592, 2012
-
(2012)
J Clin Oncol
, vol.30
, pp. 587-592
-
-
Amir, E.1
Miller, N.2
Geddie, W.3
-
101
-
-
0027043081
-
Outcome of patients hospitalized for complications after outpatient liver biopsy
-
Janes CH, Lindor KD: Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 118:96-98, 1993
-
(1993)
Ann Intern Med
, vol.118
, pp. 96-98
-
-
Janes, C.H.1
Lindor, K.D.2
-
102
-
-
41649102043
-
The cancer biomarker problem
-
Sawyers CL: The cancer biomarker problem. Nature 452:548-552, 2008
-
(2008)
Nature
, vol.452
, pp. 548-552
-
-
Sawyers, C.L.1
-
103
-
-
78649325247
-
Tumor heterogeneity in neoplasms of breast, colon, and skin
-
Li J, Wang K, Jensen TD, et al: Tumor heterogeneity in neoplasms of breast, colon, and skin. BMC Res Notes 3:321, 2010
-
(2010)
BMC Res Notes
, vol.3
, pp. 321
-
-
Li, J.1
Wang, K.2
Jensen, T.D.3
-
104
-
-
78649723255
-
PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors
-
suppl; abstr 3534
-
Kopetz S, Desai J, Chan E, et al: PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors. J Clin Oncol 28:15s, 2010 (suppl; abstr 3534)
-
(2010)
J Clin Oncol
, vol.28
-
-
Kopetz, S.1
Desai, J.2
Chan, E.3
-
106
-
-
0028174839
-
Effects of ethanol and paraformaldehyde on RNA yield and quality
-
Klimecki WT, Futscher BW, Dalton WS: Effects of ethanol and paraformaldehyde on RNA yield and quality. BioTechniques 16:1021-1023, 1994
-
(1994)
BioTechniques
, vol.16
, pp. 1021-1023
-
-
Klimecki, W.T.1
Futscher, B.W.2
Dalton, W.S.3
-
107
-
-
0026029136
-
Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction
-
Ben-Ezra J, Johnson DA, Rossi J, et al: Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem 39:351-354, 1991
-
(1991)
J Histochem Cytochem
, vol.39
, pp. 351-354
-
-
Ben-Ezra, J.1
Johnson, D.A.2
Rossi, J.3
-
108
-
-
23444462084
-
An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue
-
DOI 10.1136/jcp.2004.021352
-
Coura R, Prolla JC, Meurer L, et al: An alternative protocol for DNA extraction from formalin fixed and paraffin wax embedded tissue. J Clin Path 58:894-895, 2005 (Pubitemid 41113404)
-
(2005)
Journal of Clinical Pathology
, vol.58
, Issue.8
, pp. 894-895
-
-
Coura, R.1
Prolla, J.C.2
Meurer, L.3
Ashton-Prolla, P.4
-
109
-
-
0030726659
-
Laser capture microdissection: Molecular analysis of tissue
-
Bonner RF: Laser capture microdissection: Molecular analysis of tissue. Science 278:1481-1483, 1997
-
(1997)
Science
, vol.278
, pp. 1481-1483
-
-
Bonner, R.F.1
-
111
-
-
16544388740
-
Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH
-
Cardoso J, Molenaar L, de Menezes RX, et al: Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res 32:e146, 2004
-
(2004)
Nucleic Acids Res
, vol.32
-
-
Cardoso, J.1
Molenaar, L.2
De Menezes, R.X.3
-
112
-
-
34147164024
-
Is molecular profiling ready for use in clinical decision making?
-
Ioannidis JP: Is molecular profiling ready for use in clinical decision making? Oncologist 12:301-311, 2007
-
(2007)
Oncologist
, vol.12
, pp. 301-311
-
-
Ioannidis, J.P.1
-
113
-
-
18344396568
-
Minimum information about a microarray experiment (MIAME) - Toward standards for microarray data
-
DOI 10.1038/ng1201-365
-
Brazma A, Hingamp P, Quackenbush J, et al: Minimum information about a microarray experiment (MIAME): Toward standards for microarray data. Nat Genet 29:365-371, 2001 (Pubitemid 34326681)
-
(2001)
Nature Genetics
, vol.29
, Issue.4
, pp. 365-371
-
-
Brazma, A.1
Hingamp, P.2
Quackenbush, J.3
Sherlock, G.4
Spellman, P.5
Stoeckert, C.6
Aach, J.7
Ansorge, W.8
Ball, C.A.9
Causton, H.C.10
Gaasterland, T.11
Glenisson, P.12
Holstege, F.C.P.13
Kim, I.F.14
Markowitz, V.15
Matese, J.C.16
Parkinson, H.17
Robinson, A.18
Sarkans, U.19
Schulze-Kremer, S.20
Stewart, J.21
Taylor, R.22
Vilo, J.23
Vingron, M.24
more..
-
115
-
-
84860728924
-
-
US Food and Drug Administration: Device advice: Investigational device exemption (IDE). http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/default.htm
-
Device Advice: Investigational Device Exemption (IDE)
-
-
-
116
-
-
65449144325
-
Evaluation of next generation sequencing platforms for population targeted sequencing studies
-
Harismendy O, Ng PC, Strausberg RL, et al: Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 10:R32, 2009
-
(2009)
Genome Biol
, vol.10
-
-
Harismendy, O.1
Ng, P.C.2
Strausberg, R.L.3
-
117
-
-
70149098012
-
Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue
-
Bhagwat NR, Roginskaya VY, Acquafondata MB, et al: Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res 69:6831-6838, 2009
-
(2009)
Cancer Res
, vol.69
, pp. 6831-6838
-
-
Bhagwat, N.R.1
Roginskaya, V.Y.2
Acquafondata, M.B.3
-
118
-
-
35248874798
-
ERCC1-specific immunostaining in non-small-cell lung cancer [9]
-
DOI 10.1056/NEJMc072007
-
Olaussen KA, Fouret P, Kroemer G: ERCC1-specific immunostaining in non-small-cell lung cancer. N Engl J Med 357:1559-1561, 2007 (Pubitemid 47572656)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.15
, pp. 1559-1561
-
-
Olaussen, K.A.1
Fouret, P.2
Kroemer, G.3
-
119
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
DOI 10.1200/JCO.2006.09.2775
-
Wolff AC, Hammond ME, Schwartz JN, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145, 2007 (Pubitemid 350003059)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.1
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.H.2
Schwartz, J.N.3
Hagerty, K.L.4
Allred, D.C.5
Cote, R.J.6
Dowsett, M.7
Fitzgibbons, P.L.8
Hanna, W.M.9
Langer, A.10
McShane, L.M.11
Paik, S.12
Pegram, M.D.13
Perez, E.A.14
Press, M.F.15
Rhodes, A.16
Sturgeon, C.17
Taube, S.E.18
Tubbs, R.19
Vance, G.H.20
Van De, V.M.21
Wheeler, T.M.22
Hayes, D.F.23
more..
-
121
-
-
38549085235
-
Research ethics and the challenge of whole-genome sequencing
-
DOI 10.1038/nrg2302, PII NRG2302
-
McGuire AL, Caulfield T, Cho MK: Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet 9:152-156, 2008 (Pubitemid 351147709)
-
(2008)
Nature Reviews Genetics
, vol.9
, Issue.2
, pp. 152-156
-
-
McGuire, A.L.1
Caulfield, T.2
Cho, M.K.3
-
122
-
-
79951863517
-
Ethical and practical guidelines for reporting genetic research results to study participants: Updated guidelines from a National Heart, Lung, and Blood Institute Working Group
-
Fabsitz RR, McGuire A, Sharp RR, et al: Ethical and practical guidelines for reporting genetic research results to study participants: Updated guidelines from a National Heart, Lung, and Blood Institute Working Group. Circ Cardiovasc Genet 3:574-580, 2010
-
(2010)
Circ Cardiovasc Genet
, vol.3
, pp. 574-580
-
-
Fabsitz, R.R.1
McGuire, A.2
Sharp, R.R.3
-
123
-
-
33646254125
-
Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group
-
Bookman EB, Langehorne AA, Eckfeldt JH, et al: Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group. Am J Med Genet 140:1033-1040, 2006
-
(2006)
Am J Med Genet
, vol.140
, pp. 1033-1040
-
-
Bookman, E.B.1
Langehorne, A.A.2
Eckfeldt, J.H.3
-
124
-
-
42649145667
-
Wildtype KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
-
Amado RG, Wolf M, Peeters M, et al: Wildtype KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 26:1626-1634, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 1626-1634
-
-
Amado, R.G.1
Wolf, M.2
Peeters, M.3
-
125
-
-
54949085398
-
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
-
Karapetis CS, Khambata-Ford S, Jonker DJ, et al: K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359:1757-1765, 2008
-
(2008)
N Engl J Med
, vol.359
, pp. 1757-1765
-
-
Karapetis, C.S.1
Khambata-Ford, S.2
Jonker, D.J.3
-
126
-
-
84863400088
-
The introduction of systematic genomic testing for patients with non-small cell lung cancer (NSCLC) at Dana-Farber Cancer Institute (DFCI)
-
suppl; abstr 7517
-
Ortiz TM, Joshi VA, Heon S, et al: The introduction of systematic genomic testing for patients with non-small cell lung cancer (NSCLC) at Dana-Farber Cancer Institute (DFCI). J Clin Oncol 29:15s, 2011 (suppl; abstr 7517)
-
(2011)
J Clin Oncol
, vol.29
-
-
Ortiz, T.M.1
Joshi, V.A.2
Heon, S.3
-
127
-
-
80053371003
-
SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice
-
suppl; abstr 7518
-
Sequist LV, Heist RS, Shaw AT, et al: SNaPshot genotyping of non-small cell lung cancers (NSCLC) in clinical practice. J Clin Oncol 29:15s, 2011 (suppl; abstr 7518)
-
(2011)
J Clin Oncol
, vol.29
-
-
Sequist, L.V.1
Heist, R.S.2
Shaw, A.T.3
-
128
-
-
33748093767
-
Linking oncogenic pathways with therapeutic opportunities
-
DOI 10.1038/nrc1976, PII NRC1976
-
Bild AH, Potti A, Nevins JR: Linking oncogenic pathways with therapeutic opportunities. Nature Rev Cancer 6:735-741, 2006 (Pubitemid 44304232)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.9
, pp. 735-741
-
-
Bild, A.H.1
Potti, A.2
Nevins, J.R.3
|